JerryYoungerMD

PubMed

• 9 citations
  Tumor Tissue- versus Plasma-based Genotyping for Selection of Matched Therapy and Impact on Clinical Outcomes in Patients with Metastatic Breast Cancer.
  Neelima Vidula, Andrzej Niemierko, Giuliana Malvarosa, Megan Yuen, Jochen K. Lennerz, A. John Iafrate, Seth A. Wander, Laura Spring, Dejan Juric, Steven J. Isakoff, Je...> ;Clinical Cancer Research. 2021 Jan 27
• 25 citations
  Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases
  Jose Pablo Leone, Kyrre E. Emblem, Michelle Weitz, Rebecca Gelman, Bryan P. Schneider, Rachel A. Freedman, Jerry Younger, Marco C. Pinho, A. Gregory Sorensen, Elizabet...> ;Breast Cancer Research. 2020 Nov 30
• 26 citations
  Phase I dose-escalation trial of tucatinib in combination with trastuzumab in patients with HER2-positive breast cancer brain metastases
  O. Metzger Filho, Julieta Leone, Tianyu Li, Zhenying Tan-Wasielewski, Lorenzo Trippa, William T. Barry, Jerry Younger, Elizabeth V. Lawler, Luke Walker, Rachel A. Free...> ;Annals of Oncology. 2020 Sep 1
• 10 citations
  Identification of somatically acquired BRCA1/2 mutations by cfDNA analysis in patients with metastatic breast cancer
  Neelima Vidula, Taronish D. Dubash, Michael S. Lawrence, Antoine Simoneau, Andrzej Niemierko, Erica Blouch, Becky Nagy, Whijae Roh, Brian Chirn, Brittany A. Reeves, Gi...> ;Clinical Cancer Research. 2020 Sep 15
• 46 citations
  FGFR1 Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor-Positive (HR+) Breast Cancer.
  Joshua Z. Drago, Luigi Formisano, Dejan Juric, Andrzej Niemierko, Alberto Servetto, Seth A. Wander, Laura Spring, Neelima Vidula, Jerry Younger, Jeffrey Peppercorn, Me...> ;Clinical Cancer Research. 2019 Nov 1
• 15 citations
  Metastatic Breast Cancer With ESR1 Mutation: Clinical Management Considerations From the Molecular and Precision Medicine (MAP) Tumor Board at Massachusetts General Ho...
  Aditya Bardia, John Iafrate, Tilak K. Sundaresan, Jerry Younger, Valentina Nardi> ;The Oncologist. 2016 Sep 1
• 44 citations
  A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases
  Nan Lin, Rachel A. Freedman, Naren Ramakrishna, Jerry Younger, Anna Maria Storniolo, Jennifer R. Bellon, Steven E. Come, Rebecca Gelman, Gordon J. Harris, Mark A. Hend...> ;Breast Cancer Research and Treatment. 2013 Nov 7
• 5 citations
  Faith and mental health in an oncology population.
  Janice Bell Meisenhelder, Nancy J. Schaeffer, Jerry Younger, Marisa Lauria> ;Journal of Religion and Health. 2013 Jun 1
• 5 citations
  Circulating tumor cells as predictors of response and failure in breast cancer patients treated with preoperative chemotherapy.
  Rimoun Boutrus, Rita Abi Raad, Irene Kuter, Marek Ancukiewicz, Lisa Roberts, Natalie A. Solomon, Taylor Ngo, Heather Borick, Paula D. Ryan, Beverly Moy, Michele A. Gad...> ;The International Journal of Biological Markers. 2013 Apr 23
• 12 citations
  The non-breast-cancer death rate among breast cancer patients
  Devon Bush, Barbara L. Smith, Jerry Younger, James S. Michaelson> ;Breast Cancer Research and Treatment. 2011 May 1
• 49 citations
  Improved web-based calculators for predicting breast carcinoma outcomes.
  James S. Michaelson, L. Leon Chen, Devon Bush, Allan Fong, Barbara L. Smith, Jerry Younger> ;Breast Cancer Research and Treatment. 2011 Feb 15
• 3 citations
  Why cancer at the primary site and in the lymph nodes contributes to the risk of cancer death.
  James S Michaelson, L Leon Chen, Melvin J Silverstein, Justin A Cheongsiatmoy, Martin C Mihm Jr, Arthur J Sober, Kenneth K Tanabe, Barbara L Smith, Jerry Younger> ;Cancer. 2009 Nov 1
• 47 citations
  The impact of primary tumor size, lymph node status, and other prognostic factors on the risk of cancer death
  L. Leon Chen, Matt Nolan, Melvin J. Silverstein, Martin C. Mihm, Arthur J. Sober, Kenneth K. Tanabe, Barbara L. Smith, Jerry Younger, James S. Michaelson> ;Cancer. 2009 Nov 1
• 16 citations
  Aprepitant as salvage antiemetic therapy in breast cancer patients receiving doxorubicin and cyclophosphamide
  Paul J. Hesketh, Jerry Younger, Pedro Sanz-Altamira, Melissa Hayden, Julie Bushey, Brian Trainor, Michael Krentzin, Peter Nowd, Konstantinos Arnaoutakis, Ann M. Hesketh> ;Supportive Care in Cancer. 2009 Aug 1
• 109 citations
  VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy.
  Harold J. Burstein, Yi Chen, Leroy M. Parker, Jennifer Savoie, Jerry Younger, Irene Kuter, Paula D. Ryan, Judy Garber, Helen H.W. Chen, Susana M. Campos, Lawrence N. S...> ;Clinical Cancer Research. 2008 Dec 1
• 132 citations
  Survival in patients with brain metastases from breast cancer: the importance of HER-2 status.
  April F. Eichler, Irene Kuter, Paula D. Ryan, Lidia Schapira, Jerry Younger, John W. Henson> ;Cancer. 2008 Jun 1
• 16 citations
  DOSE-ESCALATION OF FILGRASTIM DOES NOT IMPROVE EFFICACY: CLINICAL TOLERABILITY AND LONG-TERM FOLLOW-UP ON CALGB STUDY 9141 ADJUVANT CHEMOTHERAPY FOR NODE-POSITIVE BREA...
  Minetta C. Liu, George D. Demetri, Donald A. Berry, Larry Norton, Gloria Broadwater, Nicholas J. Robert, David B. Duggan, Daniel F. Hayes, I. Craig Henderson, Alan P. ...> ;Cancer Treatment Reviews. 2008 May 1
• 349 citations
  Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer.
  Nan Lin, Lisa A. Carey, Minetta C. Liu, Jerry Younger, Steven E. Come, Matthew G. Ewend, Gordon J. Harris, Elizabeth Bullitt, Annick D. Van den Abbeele, John W. Henson...> ;Journal of Clinical Oncology. 2008 Apr 20
• 143 citations
  Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.
  Alice B. Kornblith, Mark Powell, Meredith M. Regan, Samantha Bennett, Carolyn N. Krasner, Beverly Moy, Jerry Younger, Annekathyrn Goodman, Ross S. Berkowitz, Eric P. W...> ;Psycho-Oncology. 2007 Oct 1
• 10 citations
  Rebeccamycin analog for refractory breast cancer: a randomized phase II trial of dosing schedules.
  Harold J. Burstein, Beth Overmoyer, Rebecca Gelman, Paula Silverman, Jennifer Savoie, Kathryn Clarke, L. Dumadag, Jerry Younger, Percy Ivy, Eric P. Winer> ;Investigational New Drugs. 2006 Sep 13
• 58 citations
  Efficacy of Pegfilgrastim and Darbepoetin Alfa As Hematopoietic Support for Dose-Dense Every-2-Week Adjuvant Breast Cancer Chemotherapy
  Harold J. Burstein, Leroy M. Parker, Aparna Keshaviah, Jennifer A. Doherty, Ann H. Partridge, Lidia Schapira, Paula D. Ryan, Jerry Younger, Lyndsay Harris, Beverly Moy...> ;Journal of Clinical Oncology. 2005 Nov 20
• 590 citations
  A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen.
  Xiao-Jun Ma, Zuncai Wang, Paula D Ryan, Steven J Isakoff, Anne Barmettler, Andrew Fuller, Beth Muir, Gayatry Mohapatra, Ranelle Salunga, J Todd Tuggle, Yen Tran, Diem ...> ;Cancer Cell. 2004 Jun 1
• 553 citations
  Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma
  Johanna C. Bendell, Susan M. Domchek, Harold J. Burstein, Lyndsay Harris, Jerry Younger, Irene Kuter, Craig Bunnell, Montse Rue, Rebecca Gelman, Eric Winer> ;Cancer. 2003 Jun 15
• 3 citations
  Trust Violated: Analgesics for Addicts
  Richard T. Penson, Catherine Nunn, Jerry Younger, Nancy J. Schaeffer, Bruce A. Chabner, Gregory L. Fricchione, Thomas E. Quinn, Thomas J. Lynch> ;The Oncologist. 2003 Apr 1
• 211 citations
  Preoperative Therapy With Trastuzumab and Paclitaxel Followed by Sequential Adjuvant Doxorubicin/Cyclophosphamide for HER2 Overexpressing Stage II or III Breast Cancer...
  Harold J. Burstein, Lyndsay Harris, Rebecca Gelman, Susan C. Lester, Raquel A. Nunes, Carolyn M. Kaelin, Leroy M. Parker, Leif W. Ellisen, Irene Kuter, Michele A. Gadd...> ;Journal of Clinical Oncology. 2003 Jan 1
• Join now to see all